The groundbreaking rise of Viagra has firmly established as a example of pharmaceutical success, yet its future within the broader industry now raises questions about potential gains. Copycat versions are diminishing exclusivity , prompting worries that betting on companies closely tied to Viagra's once-dominant position could be a dangerous strate